NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Feb 8, 2024 $0.114 -0.35% $0.122 X 93.44% 0
JS JS Pro
Feb 6, 2024 $0.116 -4.05% $0.124 X 93.85% 0
Feb 6, 2024 $0.130 +7.38% $0.124 V 94.96% 1
Feb 6, 2024 $0.126 +4.61% $0.124 V 97.67% 1
JS JS Pro
Feb 5, 2024 $0.121 -3.12% $0.121 V 99.92% 10
JS JS Pro
Feb 2, 2024 $0.136 +5.43% $0.125 X 91.11% 0
AlexVel AlexVel Pro
Feb 2, 2024 $0.127 -1.75% $0.125 V 98.52% 2
Feb 2, 2024 $0.139 +7.61% $0.125 X 88.86% 0
Feb 2, 2024 $0.123 -4.75% $0.125 V 98.37% 1
Feb 2, 2024 $0.120 -17.13% $0.125 V 96.08% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE